期刊文献+

转染大鼠白细胞介素10基因的骨髓源性肝干细胞移植治疗大鼠肝纤维化

Transplantation of bone marrow-derived liver stem cells transfected with rat IL-10 gene for liver fibrosis inrats
原文传递
导出
摘要 目的探讨转染大鼠白细胞介素10(IL-10)基因的β2m^-/Thy-1^+骨髓源性肝干细胞(BDLSC)移植对大鼠肝纤维化的治疗效果。方法分选Wistar大鼠的β2m^-/Thy-1^+ BDLSC,转染大鼠IL-10基因。Wistar大鼠皮下注射CCl4,制作肝纤维化模型,分为3组:(1)模型组,经大鼠门静脉分支输注无菌生理盐水1ml;(2)BDLSC组,经大鼠门静脉分支输注β2m^-/Thy-1^+ BDLSC悬液1ml(含2×10^5个细胞);(3)IL-10组,经大鼠门静脉分支输注转染IL-10基因的β2m^-/Thy-1^+ BDLSC悬液1ml(含2×10^5个细胞);另以皮下注射橄榄油的Wistar大鼠为对照(正常组)。用细胞核染色剂二脒基苯基吲哚(DAPI)标记β2m^-/Thy-1^+ BDLSC,以观察该细胞在肝内的定位情况。观察各组大鼠肝组织病理学改变和胶原的沉积情况,检测其肝功能和凝血功能。结果大鼠肝组织中可见DAPI标记的β2m^-/Thy-1^+ BDLSC。模型组大鼠的肝组织病理学改变明显,BDLSC组病理学改变有所减轻,IL-10组的组织形态最接近正常组。模型组大鼠肝组织内胶原沉积明显增多,BDLSC组胶原沉积较少,IL-10组胶原沉积明显减少。IL-10组大鼠的血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)和胆红素总量(TBIL)以及全血凝血酶原时间(PT)和活化部分凝血激酶时间(APTT)均低于模型组,差异均有统计学意义(P〈0.05),其中ALT、TBIL、PT和APTT均降至正常组水平,与BDLSC组相比较,差异有统计学意义(P〈0.05)。结论转染大鼠IL-10基因的β2m^-/Thy-1^+ BDLSC移植对大鼠肝纤维化有一定的治疗效果。 Objective To explore the curative effectiveness of transplantation of bone marrow- derived liver stem cells (BDLSCs) transfected with rat interleukin-10 (IL-10) gene in the treatment of liver fibrosis in rats. Methodsβ2m^-/Thy-1^+ BDLSCs isoJated from Wistar rats were transfected with adenovirus-mediated rat IL-10 gene. Wistar rats were subcutaneously injected with CCl4 to induce liver fibrosis, and randomly divided into three groups as follows; (1) the model group, infused with 1 ml normal saline (NS); (2) the BDLSC group, infused with NS containing untreated β2m^-/Thy-1^+ BDLSCs (2 ×10^5 cells); (3) the IL-10 group, infused with NS containing β2m^-/Thy-1^+ BDLSCs transfected with IL-10 gene (2 × 10^5 cells). Infusion was done via the portal vein. Rats subcutaneously injected with olive oil served as control (the normal group). The BDLSCs labeled with diamidine phenylindole dihydrochloride (DAPI) in the liver were localized. Pathological changes and collagen area in liver tissues were observed. Liver function and blood blotting function were tested. Results β2m^-/Thy-1^+ BDLSCs labeled with DAPI were observed in liver tissues of rats. Significant pathological changes of liver tissues were observed in the model group. Compared with the model group, pathological changes were alleviated to some extent in the BDLSC group. The morphology of liver tissue in the IL-10 group was mostly close to that in the normal group. Collagen deposition of liver tissues was increased obviously in the model group. However, transplantations of untreated and IL-10-transfected BDLSCs both reduced collagen area. Compared with the BDLSC group, collagen deposition was significantly suppressed in the IL-10 group. Transplantation of IL-10-transfected BDLSCs suppressed obviously the levels of ALT, AST, ALP, TBIL, PT and APTT as compared with the model group (P〈0. 05). The levels of ALT, TBIL, PT and APTT in the IL-10 group were significantly reduced to the normal levels as compared with those in the BDLSC group (P〈0. 05). Conclusion Transplantation of BDI.SCs transfected with rat IL-10 gene was effective in treating liver fibrosis in rats. This combined strategy of IL-10 gene and BDLSCs may represent a feasible, effective and safe therapy form for liver fibrosis.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2009年第7期403-406,共4页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金(30500236)
关键词 肝硬化 骨髓祖代细胞 白细胞介素10 Liver cirrhosis Myeloid progenitor cells Interleukin- 10
  • 相关文献

参考文献11

  • 1Lin WR,Brittan M,Alison MR.The role of bone marrowderived cells in fibrosis.Ceils Tissues Organs,2008,188(1-2):178-188.
  • 2Van Darame A,Vanden Driessche T,Collen D,et al.Bone marrow stromal cells as targets for gene therapy.Curr Gene Ther,2002,2(2):195-209.
  • 3兰玲,孙超,陈源文,李定国.大鼠β_2m^-/Thy-1^+骨髓源性肝干细胞的体外分选及鉴定[J].上海交通大学学报(医学版),2007,27(11):1293-1296. 被引量:6
  • 4兰玲,陈源文,孙超,孙巧玲,李定国.腺病毒介导的白介素10基因体外转导大鼠β_2m-/Thy-1^+骨髓源性肝干细胞[J].胃肠病学和肝病学杂志,2008,17(1):22-26. 被引量:6
  • 5Russo FP,Alison MR,Bigger BW,et al.The bone marrow functionally contributes to liver fibrosis.Gastroenterology,2006,130(6):1807-1821.
  • 6Kisseleva T,Uchinami H,Feirt N,et al.Bone marrowderived fibrocytes participate in pathogenesis of liver fibrosis.J Hepatol,2006,45(3):429-438.
  • 7di Bonzo LV,Ferrero I,Cravanzola C,et al.Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine:engraftment and hepatocyte differentiation versus profibrogenic potential Gut,2008,57(2):223-231.
  • 8Joseph B,Malhi H,Bhargava KK,et al.Kupffer cells participate in early dearance of syngeneic hepatocytes transplanted in the rat liver.Gastroenterology,2002,123(5):1677-1685.
  • 9Nussler A,Konig S,Ott M,et al Present status and perspectives of ceU-based therapies for liver diseases.J Hepatol,2006,45(1):144-159.
  • 10Ishikawa T,Terai S,Urata Y,et al.Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.Cell Tissue Res,2006,323 (2):221-231.

二级参考文献16

  • 1Lian G Wang C Teng C Zhang C Du L Zhong Q Miao C Ding M Deng H.Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro[J].中国生物学文摘,2006,20(5):24-24. 被引量:11
  • 2Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CC14-injured rats [J]. J Hepatol, 2006, 44(4): 742-748.
  • 3Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice [ J]. Hepatology,2004, 40(6): 1304-1311.
  • 4Van Damme A, Vanden Driessche T, Collen D, et al. Bone marrow stromal cells as targets for gene therapy [ J]. Curr Gene Ther, 2002, 2 (2) : 195-209.
  • 5Avital I, Inderbitzin D, Aoki T, et al. Isolation, characterization, and transplantation of bone marrow-derlved hepatocyte stem cells [ J ]. Biochem Biophys Res Commun, 2001, 288( 1 ) : 156-164.
  • 6Shackel N,Rockey D. In pursuit of the " Holy Grail"-stem cells, hepatic injury, fibrogenesis and repair [J]. Hepatology, 2005, 41 ( 1 ) : 16-18.
  • 7Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs [J]. Exp Hematol, 2005, 33(1) : 108-119.
  • 8Kanazawa Y,Verma IM. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver [ J ]. Proc Natl Acad Sci U S A, 2003, 100 (Suppl 1): 11850-11853.
  • 9Baba S, Fujii H, Hirose T, et al. Commitment of bone marrow cells to hepatic stellate cells in mouse [ J ]. J Hepatol, 2004, 40 ( 2 ) : 255 -260.
  • 10Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis [ J ]. J Hepatol, 2006, 45(3) : 429-438.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部